BL-918
BL-918 is an orally active UNC-51-like kinase 1 (ULK1) activator with an EC50 of 24.14 nM. BL-918 exerts its cytoprotective autophagic effect by targeting ULK complex. BL-918 has the potential for Parkinson’s disease (PD) treatment[1].
Product Specifications
CAS Number
2101517-69-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; ULK
Type
Reference compound
Related Pathways
Autophagy
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bl-918.html
Purity
99.72
Solubility
DMSO : ≥ 250 mg/mL
Smiles
O=C(NC1=CC=C(F)C=C1F)[C@H](NC(NC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)=S)C3=CC=CC=C3
Molecular Formula
C23H15F8N3OS
Molecular Weight
533.44
Precautions
H302, H315, H319, H335
References & Citations
[1]Ouyang L, et al. Small-Molecule Activator of UNC-51-Like Kinase 1 (ULK1) That Induces Cytoprotective Autophagy for Parkinson's Disease Treatment. J Med Chem. 2018 Apr 12;61 (7) :2776-2792.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ULK1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP14216PU-N 400 µL
Pumilio 1 (PUM1) (N-term) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
BNC741372-100 1x 100 µL
Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (EGP40/1372), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 